15 pharmaceutical companies were damaged in the war.
Fluidity and supply of raw materials, the main challenges of pharmaceutical production.
Muhammad Hashemi, spokesman for the Food and Drug Organization, in an interview with Mizen: Despite the damage caused to part of the country's pharmaceutical industry infrastructure in the war, the production and supply of drugs did not stop and the country's drug network continued to operate relying on existing capabilities.
Some units faced activity restrictions or temporary closures due to the damage caused, and their return to sustainable production capacity depends on the amount of damage and the process of supplying the equipment and raw materials.
During the recent attacks, 15 drug manufacturing companies and 8 active drug distribution companies were hit.
The specific conditions of the country may affect the production process, the supply of raw materials or the activity of some of the units, but these conditions do not mean a change in the quality requirements and standards of drug production.
Out of a total of about 700 essential and essential medicines in Israel, the supply of 37 involves difficulties, some of which stem from the existing restrictions on supply and import.
More details.
Rank in social networks.